To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis

NCT02385318 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

519

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis

Interventions

DRUG: Ingenol Mebutate (Perrigo)
DRUG: Ingenol Mebutate (Reference)
DRUG: Placebo gel

Sponsor

Padagis LLC